US Patent Litigations are now available. Check here

Explore Samyang Biopharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP2759294Nov 1, 2017Percutaneously Absorbable Preparation Containing Fentanyl And A Homologue Thereof1